LAS VEGAS, Jan. 12 (Xinhua) -- Artificial intelligence (AI), a rapidly evolving technology driving breakthroughs across industries, took center stage at the Consumer Electronics Show (CES) 2025.

Dec. 20, 2024 — Using an AI tool, researchers have analyzed brain images from 70-year-olds and ... 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Advanced Micro Devices is investing $20 million in Absci, a drug-discovery company based in Washington state, in a move aimed at selling its artificial intelligence chips in the healthcare sector.

Novo Nordisk (NVO) and Valo Health expand collaboration to develop new treatments targeting cardiometabolic diseases. Read ...

This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at all stages of the drug discovery and design journey. Robust process ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

an expert in using machine learning algorithms to analyse images. The power of phenotypic screening was illustrated by a 2011 paper in Nature Reviews Drug Discovery that analysed how new medicines ...

“We have seen remarkable progress as far as AI’s impact on drug discovery, from target identification and drug design to preclinical safety and beyond—and this innovation has catalyzed and ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins Some states have laws and ethical rules regarding solicitation and ...